SpironolactoneDiureticsAntihypertensive AgentsMineralocorticoid Receptor AntagonistsCanrenoneHypertensionSodium Chloride Symporter InhibitorsHydrochlorothiazideAldosteroneBlood PressureHyperkalemiaFurosemideChlorthalidoneCanrenoic AcidBendroflumethiazideAngiotensin-Converting Enzyme InhibitorsReceptors, MineralocorticoidTriamtereneBenzothiadiazinesChlorothiazideAmlodipineDrug Therapy, CombinationPregnadienesDiuresisAtenololMethyldopaAngiotensin II Type 1 Receptor BlockersRats, Inbred SHRTrichlormethiazideReninCalcium Channel BlockersHyperaldosteronismHypokalemiaFludrocortisoneAdrenergic beta-AntagonistsDoxazosinHeart FailurePotassiumDouble-Blind MethodMetolazoneTetrazolesHydralazineIndapamideThiazidesCaptoprilEnalaprilSodium Potassium Chloride Symporter InhibitorsGynecomastiaTreatment OutcomeBlood Pressure Monitoring, AmbulatoryLosartanMineralocorticoidsAngiotensin Receptor AntagonistsLisinoprilRenin-Angiotensin SystemSodiumKidneyHypertrophy, Left VentricularTime FactorsBenzimidazolesDose-Response Relationship, DrugHeart RateNatriuresisBlood Pressure DeterminationElectrolytesRats, Inbred WKYHypertension, RenalDigoxinEndomyocardial FibrosisDihydralazineBiphenyl CompoundsRisk FactorsLabetalolDihydropyridinesAmilorideFollow-Up StudiesProspective StudiesCross-Over StudiesAngiotensin IISystoleCilazaprilDesoxycorticosteroneHirsutismClinical Trials as TopicNifedipineBumetanidePerindoprilCreatinineEthacrynic AcidGlomerular Filtration RateHypertension, RenovascularMinoxidilDrug InteractionsRats, WistarPatient ComplianceMifepristoneFelodipineProteinuriaDiet, Sodium-RestrictedNicardipine